Key result
Tailored catheter ablation targeting specific arrhythmogenic substrates, such as the right atrium, successfully terminated atrial arrhythmias in two patients with Chagas' cardiomyopathy.
Why the study?
No publications currently address the ablation of atrial fibrillation in patients with Chagas cardiomyopathy or the characteristics of the arrhythmia such as successful ablation sites.
Case Report (n=2)
This report provides early evidence on the characteristics and tailored ablation approach for atrial fibrillation in patients with Chagas' cardiomyopathy.
Hypothesis-generating for tailored ablation in Chagas' cardiomyopathy; larger studies needed before clinical adoption.
There is extensive knowledge in the ablation of ventricular arrhythmias in patients with Chagas' cardiomyopathy, as well as specific characteristics of the arrhythmogenic substrate, and the need for an epicardial approach to achieve success. On the contrary, no publications currently address the ablation of atrial fibrillation in these patients or the characteristics of the arrhythmia such as the successful ablation sites. Our two case reports highlight the association of Chagas' disease with atrial arrhythmias, the tailored approach that was needed to give an appropriate treatment and a discussion of our current knowledge of Chagas' cardiomyopathy as a substrate for atrial arrhythmias.
No takes yet. Share an insight, caveat, or question.
Jorge Omar Osorio Díaz (2018) conducted a case report in Atrial arrhythmias in Chagas' cardiomyopathy (n=2). Tailored catheter ablation was evaluated on Successful termination of atrial arrhythmia. Tailored catheter ablation targeting specific arrhythmogenic substrates, such as the right atrium, successfully terminated atrial arrhythmias in two patients with Chagas' cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: